Loading patent…
AssigneeUniversity of Georgia Research Foundation, Inc.
InventorsMichael P. Doyle, Tong Zhao, Barry G. Harmon, Cathy Ann Brown
Estimating the term…
The prevention and treatment of carriage of E. coli O157:H7 by a ruminant animal is accomplished by administering dominant probiotic bacteria to the animal. The dominant probiotic bacteria prevent the establishment of E. coli O157:H7 when inoculated prior to administering E. coli O157:H7, are reisolatable from the gastrointestinal tract of inoculated animals for up to 28 days post-inoculation, and are capable of reducing or eliminating E. coli O157:H7 from animals previously inoculated with the pathogen. In particular, the dominant probiotic bacteria are strains E. coli 271 ATCC 202020, E. coli 786 ATCC 202018 and E. coli 797 ATCC 202019.
A biologically pure culture having all of the identifying characteristics of a microorganism selected from the group of dominant probiotic bacteria consisting of E. coli 271, ATCC accession number 202020, E. coli 786, ATCC accession number 202018, and E. coli 797, ATCC accession number 202019.
A method for selecting dominant probiotic bacteria comprising the steps of:
An inoculant composition comprising a carrier and one or more strains of dominant probiotic bacteria selected from the group consisting of E. coli 271 ATCC 202020, E. coli 786 ATCC 202018 and E. coli 797 ATCC 202019.
Dependencies are inferred from the claim text.